A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.

ABSTRACT:

SUBMITTER: Shaurova T 

PROVIDER: S-EPMC10091104 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature